Nonallergic Rhinopathy (Formerly Known as Vasomotor Rhinitis)

Immunology and Allergy Clinics of North America

Volumn 31, Issue 3, 2011, Pages 441-455

  Kaliner, Michael A ^a,b,c  

^a Institute for Asthma and Allergy   (United States)

^b Institute for Asthma and Allergy   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Allergic rhinitis; Nasal antihistamines; Nasal corticosteroids; Nonallergic rhinopathy; Vasomotor rhinitis

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; AZELASTINE; BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT; CAPSAICIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUTICASONE; FLUTICASONE PROPIONATE; IPRATROPIUM BROMIDE; METHYLDOPA; METHYLSCOPOLAMINE; OLOPATADINE; ORAL CONTRACEPTIVE AGENT; OXYMETAZOLINE; PHENYLEPHRINE; PLACEBO; PSEUDOEPHEDRINE; RESERPINE;

ALLERGIC RHINITIS; ASPIRIN EXACERBATED RESPIRATORY DISEASE; DISEASE CLASSIFICATION; GLAUCOMA; HEART PALPITATION; HEART STIMULATION; HUMAN; INFLAMMATION; INSOMNIA; NEUROLOGIC DISEASE; NONALLERGIC RHINITIS WITH EOSINOPHILIA SYNDROME; NOSE CONGESTION; NOSE MUCOSA; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHINORRHEA; SEDATION; SIDE EFFECT; SYMPTOMATOLOGY; URINARY HESITANCY; VASOMOTOR RHINITIS; XEROSTOMIA;

HUMANS; PREVALENCE; RHINITIS, VASOMOTOR;

EID: 79959960559     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2011.05.007     Document Type: Review

References (62)

1. Baraniuk J.N., Shusterman D. Nonallergic rhinitis 2007, Informa Healthcare, New York.
2. Baraniuk J.N. Pathogenic mechanisms of idiopathic nonallergic rhinitis. World Allergy Organiz J 2009, 2:106-114.
3. Kaliner M.A., Baraniuk J.N., Benninger M., et al. Consensus definition of nonallergic rhinopathy (NAR), previously referred to as vasomotor rhinitis (VMR), nonallergic rhinitis, and/or idiopathic rhinitis. WAO J 2009, 2(6):119-120.
4. Nassef M., Shapiro G., Casale T.B., et al. Identifying and managing rhinitis and its subtypes: allergic and nonallergic components-a consensus report and materials from the Respiratory and Allergic Disease Foundation. Curr Med Res Opin 2006, 22:2541-2548.
5. Bernstein J.A., Rezvani M. Mixed rhinitis: a new subclass of chronic rhinitis?. Current review of rhinitis 2006, 69-78. Current Medicine, Philadelphia. 2nd edition. M. Kaliner (Ed.).
6. Brandt D., Bernstein J.A. Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis. Ann Allergy Asthma Immunol 2006, 96:526-532.
7. Brandt D., Bernstein J.A. Questionnaire diagnosis of non-allergic rhinitis. Nonallergic rhinitis 2008, 55-68. Marcel Dekker, Inc, New York. J.N. Baraniuk, D. Shusterman (Eds.).
8. Bernstein J.A., Brandt D., Ratner P., et al. Assessment of a rhinitis questionnaire in a seasonal allergic rhinitis population. Ann Allergy Asthma Immunol 2008, 100:512-513.
9. Bernstein JA, Brandt DM, Martin V. Differentiation of chronic rhinitis subtypes using an Irritant Index Scale. Presented at the American College of Allergy, Asthma and Immunology Annual Meeting. Dallas (TX), November 8-13, 2007.
10. Settipane R.A., Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001, 86:494-508.
11. Wallace D.V., Dykewicz M.S., Bernstein D.I., Joint Task Force on Practice; American Academy of Allergy, Asthma & Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008, 122(Suppl 2):S1-S84.
12. Mullarkey M.F., Hill J.S., Webb D.R. Allergic and nonallergic rhinitis: their characterization with attention to the meaning of nasal eosinophilia. J Allergy Clin Immunol 1980, 65:122-126.
13. Enberg R.N. Perennial nonallergic rhinitis: a retrospective review. Ann Allergy Asthma Immunol 1989, 63:513-516.
14. Togias A. Age relationships and clinical features of nonallergic rhinitis. J Allergy Clin Immunol 1990, 85:182.
15. Leynaert B., Bousquet J., Neukirch C., et al. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects. Results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999, 104:301-304.
16. Settipane R.A. Rhinitis: a dose of epidemiological reality. Allergy Asthma Proc 2003, 24:147-154.
17. Mercer M.J., van der Linde G.P., Joubert G. Rhinitis (allergic and nonallergic) in an atopic pediatric referral population in the grasslands of inland South Africa. Ann Allergy Asthma Immunol 2002, 89:503-512.
18. Bachert C., van Cauwenberge P., Olbrecht J., et al. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy 2006, 61:693-698.
19. Mølgaard E., Thomsen S.F., Lund T., et al. Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy 2007, 62:1033-1037.
20. Schatz M., Zeiger R.S., Chen W., et al. The burden of rhinitis in a managed care organization. Ann Allergy Asthma Immunol 2008, 101:240-247.
21. Settipane R.A., Charnock D.R. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol 2007, 19:23-34.
22. Bernstein I.L., Li J.T., Bernstein D.I., American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology, et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol 2008, 100(3 Suppl 3):S1-S148.
23. Kaliner M., Baraniuk J.N., Benninger M.S., et al. Consensus description of inclusion and exclusion criteria for clinical studies of nonallergic rhinopathy, previously referred to as vasomotor rhinitis (VMR) nonallergic rhinitis or idiopathic rhinitis. World Allergy Organiz J 2009, 2:180-184.
24. Ray N.F., Baraniuk J.N., Thamer M., et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in the United States in 1996, including contributions of related airway illnesses. J Allergy Clin Immunol 1999, 103:401-407.
25. Reed S.D., Lee T.A., McCrory D.C. The economic burden of allergic rhinitis: a critical evaluation of the literature. Pharmacoeconomics 2004, 22:345-361.
26. Settipane R.A., Settipane G.A. Nonallergic rhinitis. Current review of rhinitis 2006, 55-68. Current Medicine, Philadelphia. 2nd edition. M.A. Kaliner (Ed.).
27. Kaliner M, Lieberman P. Incidence of allergic, nonallergic and mixed rhinitis in clinical practice. Presented at the Annual Meeting of the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNS) Foundation. Washington, DC, September 24-27, 2000; Poster PO75.
28. Bousquet J., Fokkens W., Burney P., et al. Important research questions in allergy and related diseases: nonallergic rhinitis: a GALEN paper. Allergy 2008, 63:842-853.
29. Scarupa M.D., Kaliner M.A. Nonallergic rhinitis, with a focus on vasomotor rhinitis: clinical importance, differential diagnosis, and effective treatment recommendations. World Allergy Organiz J 2009, 2:20-25.
30. Greiner A.N., Meltzer E.O. Pharmacologic rationale for treating allergic and nonallergic rhinitis. J Allergy Clin Immunol 2006, 118:985-996.
31. Kaliner M.A. Classification of nonallergic rhinitis syndromes with a focus on vasomotor rhinitis, proposed to be known henceforth as nonallergic rhinopathy. World Allergy Organiz J 2009, 2:98-101.
32. Kaliner M.A. Recognizing and treating nonallergic rhinitis. Female Patient 2002, 27:20-32.
33. Graf P.M. Rhinitis medicamentosa. Nonallergic rhinitis 2007, 295-304. Informa, New York. J.N. Baraniuk, D. Shusterman (Eds.).
34. Baraniuk J.N., Clauw D.J., Gaumond E. Rhinitis symptoms in chronic fatigue syndrome. Ann Allergy Asthma Immunol 1998, 81:359-365.
35. Raphael G., Raphael M.H., Kaliner M. Gustatory rhinitis: a syndrome of food-induced rhinorrhea. J Allergy Clin Immunol 1989, 83:110-115.
36. Hellgren J., Toren K. Nonallergic occupational rhinitis. Nonallergic rhinitis 2007, 241-248. Informa, New York. J.N. Baraniuk, D. Shusterman (Eds.).
37. Wedback A., Enbom H., Eriksson N.E., et al. Seasonal nonallergic rhinitis (SNAR)-a new disease entity? A clinical and immunological comparison between SNAR, seasonal allergic rhinitis and persistent non-allergic rhinitis. Rhinology 2005, 43:86-92.
38. Togias A., Lykens K., Kagey-Sobotka A., et al. Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose. Am Rev Respir Dis 1990, 141:1428-1433.
39. Meltzer E.O. The treatment of vasomotor rhinitis with intranasal corticosteroids. World Allergy Organiz J 2009, 2:166-179.
40. Webb D.R., Meltzer E.O., Finn A.F., et al. Intranasal fluticasone is effective for perennial nonallergic rhinitis with or without eosinophilia. Ann Allergy Asthma Immunol 2002, 88:385-390.
41. Day J.H., Andersson C.B., Briscoe M.P. Efficacy and safety of intranasal budesonide in the treatment of perennial rhinitis in adults and children. Ann Allergy Asthma Immunol 1990, 64(5):445-450.
42. Lundblad L., Sipila P., Farstad T., et al. Mometasone furoate nasal spray in the treatment of perennial non-allergic rhinitis: a Nordic, multicenter, randomized, double-blind, placebo-controlled study. Acta Otolaryngol 2001, 121(4):505-509.
43. Blom H.M., Godthelp T., Fokkens W.J., et al. The effect of nasal steroid aqueous spray on nasal complaint scores and cellular infiltrates in the nasal mucosa of patients with nonallergic, noninfectious perennial rhinitis. J Allergy Clin Immunol 1997, 100:739-747.
44. Broms P., Malm L. Oral vasoconstrictors in perennial non-allergic rhinitis. Allergy 1982, 37:67-74.
45. Kaliner M.A. Azelastine and olopatadine in the treatment of allergic rhinitis. Ann Allergy Asthma Immunol 2009, 103:373-380.
46. Kaliner M.A. A novel and effective approach to treating rhinitis with nasal antihistamines. Ann Allergy Asthma Immunol 2007, 99:383-391.
47. Banov C.H., Lieberman P., Vasomotor Rhinitis Study Groups Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol 2001, 86(1):28-35.
48. Yanez A., Rodrigo G.J. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2002, 89:479-484.
49. Kaliner M.A., Berger W.E., Ratner R.H., et al. The role of intranasal antihistamines in the treatment of allergic rhinitis, IV: efficacy of intranasal antihistamines. Ann Allergy Asthma Immunol 2011, 106(Suppl):S6-S11.
50. Kaliner M.A., Storms W., Tilles S., et al. Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis. Allergy Asthma Proc 2009, 30:255-262.
51. Data on file, Meda Pharmaceuticals Inc, Somerset.
52. Ratner P.H., Hampel F., Van Bavel J., et al. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2008, 100:74-81.
53. Hampel F.C., Ratner P.H., Van Bavel J., et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Ann Allergy Asthma Immunol 2010, 105:168-173.
54. LaForce C.F., Carr W., Tilles S.A., et al. Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis. Allergy Asthma Proc 2010, 31:132-140.
55. Silvers W.S. The skier's nose: a model of cold-induced rhinorrhea. Ann Allergy Asthma Immunol 1991, 67:32-36.
56. Bonadonna P., Senna G., Zanon P., et al. Cold-induced rhinitis in skiers-clinical aspects and treatment with ipratropium bromide nasal spray: a randomized controlled trial. Am J Rhinol 2001, 15:297-301.
57. Milgrom H., Biondi R., Georgitis J.W., et al. Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children. Ann Allergy Asthma Immunol 1999, 83(2):105-111.
58. Dockhorn R., Aaronson D., Bronsky E., et al. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. Ann Allergy Asthma Immunol 1999, 82(4):349-359.
59. Van Rijswijk J.B., Boeke E.L., Keizer J.M., et al. Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis: a double-blind randomized application regimen study. Allergy 2003, 58:754-761.
60. Ozcan C., Vayisoglu Y., Dogu O., et al. The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis. Am J Otolaryngol 2006, 27(5):314-318.
61. Ikeda K., Oshima T., Suzuki M., et al. Functional inferior turbinosurgery (FITS) for the treatment of resistant chronic rhinitis. Acta Otolaryngol 2006, 126:739-745.
62. Scarupa M.D., Kaliner M.A. Adjuvant therapies in the treatment of acute and chronic rhinosinusitis. Chronic rhinosinusitis 2007, Marcel Dekker, New York, p. 251-63. D. Hamilos, F. Baroody (Eds.).